Cancro do pulmão de não pequenas células: Comparação entre o estadiamento clínico e o patológico

摘要: Lung cancer (LC) staging remains a clinical challenge as it determines the disease’s prognosis and treatment. Surgery is best option for controlling non-small cell lung (NSCLC) only potential cure. In this setting, helps select patients who will benefit from surgery, excluding inoperable including with resectable lesions. The aim of study to compare (TNMc) pathological (TNMp) evaluate diagnosis, complementary treatment survival these patients. This retrospective that included or highly suspicious lesions had undergone surgery were followed up in Hospital de Sao Joao unit between January 1999 December 2003. It based on files pathology reports. 73.3% group 60 male, median age 59.2 years. most frequent TNMc stages 41.7% T1N0M0 36.7% T2N0M0. Thoracotomy therapeutic purpose was performed 80% thoracotomy diagnostic also remaining 20%. 6.7% resection incomplete. TNMp T2N0p 33.3%, T2N1p 15.0% T2N2p 13.3%. There significant difference two types, upstaging 65.0%, down 67% 28.3% keeping same stage. differences T1N0c T2N0c T2N1p. global agreement both methods 21.7%. Median 43 months. In conclusion, while less accurate, did not determine important changes strategy survival. For future, we should consider using other tools biological factors complement anatomical information currently use. Rev Port Pneumol 2006; XII (4): 337-357